MedTech Dive January 2, 2025
Elise Reuter

Kolaleh Eskandanian, chief innovation officer at Children’s National Hospital, said the partnership is meant to address the many challenges with developing devices for children and infants.

A collaboration between a children’s hospital and the Food and Drug Administration aims to address challenges in developing medical devices for children and infants.

Children’s National Hospital in Washington, D.C., struck a five-year research collaboration with the FDA’s Office of Science and Engineering Laboratories (OSEL) to build regulatory science tools to help evaluate pediatric devices.

The partners will use de-identified clinical data, multimodal imaging and machine learning to develop open-source tools that can be used to design and test devices more efficiently.

Currently, few high-risk devices are labeled for pediatric use,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Interview / Q&A, Medical Devices, Trends
Aluminum, steel tariffs expected to impact medical devices
Neuralink competitor Paradromics secures investment from Saudi Arabia's Neom
Report: Johnson & Johnson wants to sell its stroke business for more than $1B
How Trump’s trade fight could impact the medical device industry
The LIBERTAS Study: Q&A with Biljana Naumovic of J&J

Share This Article